Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
570 studies found for:    Open Studies | "Hematopoietic Stem Cells"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Pilot Study Using Propranolol To Promote Prenylation Of The Gtpase Rap1b In Hematopoietic Stem Cell Transplant Recipients
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Blood Draw
2 Recruiting Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Allogeneic Hematopoietic Stem Cell
Interventions: Biological: fecal microbiota transplantation (FMT);   Other: No fecal microbiota transplantation (FMT), routine management
3 Recruiting Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers
Condition: Post Hematopoietic Stem Cell Transplantation
Intervention: Behavioral: semi-structured interviews
4 Recruiting Dose Finding Study of Vedolizumab for Graft-Versus-Host Disease (GvHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation
Intervention: Drug: Vedolizumab
5 Recruiting T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplant;   Poor Marrow Graft Function
Interventions: Procedure: Donor peripheral blood progenitor cells: stimulation, harvesting, isolation and T-cell depletion;   Device: CliniMACS Cell Selection System
6 Recruiting Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Interventions: Biological: Recipients;   Biological: Donors
7 Recruiting Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
Conditions: Term and Preterm Neonates (24-41 Weeks Gestational Age);   Hematopoietic Stem Cell Transplant Recipient Children
Interventions: Other: Tubes fund recovery blood count;   Other: the rest of the blood test and stool sample
8 Recruiting Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Conditions: Leukemia, Myeloid, Acute;   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Procedure: Haploidentical Stem Cell Transplantation
9 Recruiting Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: ATG
10 Recruiting Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Data Collection
11 Recruiting Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant
Conditions: Hematopoietic Stem Cell Transplantation;   Stem Cell Transplantation, Hematopoietic;   Transplantation, Hematopoietic Stem Cell
Intervention:
12 Recruiting A Pharmacokinetic Study of Melphalan in Children
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: Melphalan
13 Recruiting A Multi-Institutional Phase II Feasibility Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Conditions: Neuroepithelial Tumor;   Solid Tumor;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Procedure: Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy;   Drug: Keratinocyte Growth Factor;   Drug: Alemtuzumab;   Drug: Thiotepa;   Drug: Etoposide;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil
14 Not yet recruiting Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
Conditions: Acute Myeloid Leukemia;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Sorafenib
15 Recruiting Gut Decontamination In Pediatric Allogeneic Hematopoietic
Conditions: Hematopoietic Stem Cell Transplantation (HSCT);   Acute GVH Disease
Intervention: Drug: Vancomycin-polymyxin B
16 Recruiting Intrabone Infusion of Umbilical Cord Blood Stem Cells
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Procedure: Intrabone infusion of umbilical cord blood stem cells
17 Recruiting Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
Conditions: Hematopoietic Stem Cell Transplantation;   Vancomycin-Resistant Enterococci
Interventions: Other: Theraworx™ bath wipes;   Other: Standard bath wipes
18 Recruiting TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
Conditions: Primary Immune Deficiency Disorder;   Hematopoietic Stem Cell Transplantation
Intervention: Other: Biological: TCR alfa beta T cell depletion
19 Not yet recruiting Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT
Conditions: Myelodysplastic Syndrome;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Drug: Decitabine;   Drug: CAG chemotherapy regimen;   Drug: G-CSF+Decitabine+BUCY Conditioning Regimen
20 Recruiting Hemostatic Complications in Hematopoietic Stem Cell Transplantation
Condition: Hemostatic Disorders
Intervention: Drug: thrombopoietin, interleukin-11, heparin,

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.